BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lind L, Johansson L, Ahlström H, Eriksson JW, Larsson A, Risérus U, Kullberg J, Oscarsson J. Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population. World J Hepatol 2020; 12(4): 149-159 [PMID: 32685107 DOI: 10.4254/wjh.v12.i4.149]
URL: https://www.wjgnet.com/1948-5182/full/v12/i4/149.htm
Number Citing Articles
1
Updated S2k Clinical Practice Guideline on Non-alcoholic Fatty Liver Disease (NAFLD) issued by the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) – April 2022 – AWMF Registration No.: 021–025Zeitschrift für Gastroenterologie 2022; 60(09): e733 doi: 10.1055/a-1880-2388
2
Katarzyna Kozłowska-Petriczko, Ewa Wunsch, Jan Petriczko, Wing-Kin Syn, Piotr Milkiewicz. Diagnostic Accuracy of Non-Imaging and Ultrasound-Based Assessment of Hepatic Steatosis Using Controlled Attenuation Parameter (CAP) as ReferenceJournal of Clinical Medicine 2021; 10(7): 1507 doi: 10.3390/jcm10071507
3
Ilias D. Vachliotis, Maria F. Vasiloglou, Aikaterini Kapama, Dimitrios Matsagkos, Antonis Goulas, Paraskevi Papaioannidou, Stergios A. Polyzos. Association between hepatic steatosis and fibrosis indices and dietary habits, physical activity, and quality of lifeArab Journal of Gastroenterology 2022;  doi: 10.1016/j.ajg.2022.05.006
4
Marcin Kosmalski, Józef Drzewoski, Izabela Szymczak-Pajor, Andrzej Zieleniak, Melania Mikołajczyk-Solińska, Jacek Kasznicki, Agnieszka Śliwińska. Irisin Is Related to Non-Alcoholic Fatty Liver Disease (NAFLD)Biomedicines 2022; 10(9): 2253 doi: 10.3390/biomedicines10092253
5
Vincenza Di Stasi, Elisa Maseroli, Giulia Rastrelli, Irene Scavello, Sarah Cipriani, Tommaso Todisco, Sara Marchiani, Flavia Sorbi, Massimiliano Fambrini, Felice Petraglia, Mario Maggi, Linda Vignozzi. SHBG as a Marker of NAFLD and Metabolic Impairments in Women Referred for Oligomenorrhea and/or Hirsutism and in Women With Sexual DysfunctionFrontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.641446
6
Nancy de los Ángeles Segura-Azuara, Carlos Daniel Varela-Chinchilla, Plinio A. Trinidad-Calderón. MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis DiagnosisFrontiers in Medicine 2022; 8 doi: 10.3389/fmed.2021.774079
7
Christoph G Dietrich, Monika Rau, Andreas Geier. Screening for nonalcoholic fatty liver disease-when, who and how?World Journal of Gastroenterology 2021; 27(35): 5803-5821 doi: 10.3748/wjg.v27.i35.5803
8
Jacob V. DiBattista, Daniel A. Burkholder, Anna S. Lok, Vincent L. Chen. Accuracy of Non-invasive Indices for Diagnosing Hepatic Steatosis Compared to Imaging in a Real-World CohortDigestive Diseases and Sciences 2022;  doi: 10.1007/s10620-022-07415-w
9
E. Roeb, A. Canbay, H. Bantel, J. Bojunga, J. de Laffolie, M. Demir, U. W. Denzer, A. Geier, W. P. Hofmann, C. Hudert, T. Karlas, M. Krawczyk, T. Longerich, T. Luedde, M. Roden, J. Schattenberg, M. Sterneck, A. Tannapfel, P. Lorenz, F. Tacke. Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025Zeitschrift für Gastroenterologie 2022; 60(09): 1346 doi: 10.1055/a-1880-2283
10
Chang-Hoon Lee, Kyung-Do Han, Da Hye Kim, Min-Sun Kwak. The Repeatedly Elevated Fatty Liver Index Is Associated With Increased Mortality: A Population-Based Cohort StudyFrontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.638615
11
Matheus Mathedi CONCON, Martinho Antonio GESTIC, Murillo Pimentel UTRINI, Felipe David Mendonça CHAIM, Elinton Adami CHAIM, Everton CAZZO. SHOULD ROUTINE LIVER BIOPSY BE CONSIDERED IN BARIATRIC SURGICAL PRACTICE? AN ANALYSIS OF THE LIMITATIONS OF NON-INVASIVE NAFLD MARKERSArquivos de Gastroenterologia 2022; 59(1): 110 doi: 10.1590/s0004-2803.202200001-19